샘플 요청 목록

 카트 문의
시장보고서
상품코드
1797343

세계의 IVD 원료 시장

IVD Raw Materials
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 381 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

IVD 원료 세계 시장은 2030년까지 358억 달러에 달할 전망

2024년에 277억 달러로 추정되는 IVD 원료 세계 시장은 분석 기간인 2024-2030년에 CAGR 4.3%로 성장하여 2030년에는 358억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 IVD 항체·항원은 CAGR 3.8%를 기록하며 분석 기간 종료시에는 130억 달러에 달할 것으로 예측됩니다. IVD 효소 분야의 성장률은 분석 기간 동안 CAGR 5.0%로 추정됩니다.

미국 시장은 76억 달러로 추정, 중국은 CAGR 7.8%로 성장 예측

미국의 IVD 원료 시장은 2024년에 76억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 73억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 7.8%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.8%와 3.4%로 예측됩니다. 유럽에서는 독일이 CAGR 2.5%로 성장할 것으로 예측됩니다.

세계의 IVD 원료 시장 - 주요 동향과 촉진요인 정리

체외진단약의 신뢰성에 있어 원료의 역할은 무엇인가?

IVD 원료란 체외진단용 검사 및 키트 제조에 사용되는 필수적인 생물학적, 화학적, 합성 성분을 말합니다. 항체, 항원, 효소, 뉴클레오티드, 시약, 완충액, 안정제, 대조물질 등이 포함됩니다. 이러한 원료의 품질, 일관성 및 성능은 질병의 검출, 모니터링 및 스크리닝에 사용되는 진단 분석의 민감도, 특이성 및 재현성에 직접적인 영향을 미칩니다.

분자진단, 현장진단, 감염성 질환 감시가 증가함에 따라 신뢰할 수 있는 IVD 원료에 대한 수요가 급증하고 있습니다. 제조업체는 규제 준수와 분석의 신뢰성을 보장하기 위해 고순도, 다량의 원재료를 조달할 필요가 있습니다. 생명공학 기업 및 연구 개발도 종양학, 심장병학, 감염학 분야의 새로운 검사 포맷을 개발할 때 IVD 등급 원료에 의존하고 있습니다.

어떤 혁신이 자재 조달과 품질 보증을 변화시키고 있는가?

IVD 원료 공급업체는 엄격한 품질 기준을 충족하기 위해 첨단 정제 공정, 발현 시스템, 재조합 생산 기술에 투자하고 있습니다. 단클론항체 생산, 합성 펩타이드 합성, 효소 공학은 높은 수율과 반복 가능한 배치를 제공하기 위해 개선되고 있습니다. 재조합 항원이나 핵산 프로브는 고정밀 검사 키트에서 변동이 심한 생물학적 물질을 대체하기 위해 사용되고 있습니다.

재료 공급업체는 안정성 테스트, 성능 문서화, 추적 가능한 로트 기록이 있는 검증된 원료를 제공하여 IVD 제조업체가 규제 당국에 제출하는 것을 간소화합니다. 검사 개발자들이 신뢰할 수 있고, 확장성이 있으며, 감사에 대응할 수 있는 공급업체를 찾는 가운데, GMP 준수 제조, ISO 인증, 세계 유통 능력은 필수 조건이 되고 있습니다. 공중보건 위기나 수요 급증 시에도 공급이 끊기지 않도록 수직통합형 생산라인을 개발하는 회사도 있습니다.

수요 집중 지역과 주요 바이어는?

진단키트 제조업체, 분자 검사 개발 기업, 표준 검사 기관에서 수요가 가장 강합니다. PCR 기반 진단약, ELISA 키트, 측면 흐름 분석, 시퀀싱 플랫폼을 개발하는 기업들은 특정 검출 표적에 맞는 다양한 원재료에 의존하고 있습니다. 연구기관과 생명공학 기업들도 분석 개발 및 임상 검증을 위해 IVD 등급의 원료를 구매하고 있습니다.

북미와 유럽은 진단 의약품 기업이 집중되어 있고 규제가 엄격하기 때문에 여전히 주요 시장입니다. 아시아태평양은 현지 생산에 대한 노력, 질병 감시 확대, 수출 능력의 증가로 인해 빠르게 성장하고 있습니다. 공중 보건 연구소, 학술 기관, 위탁 진단 제조업체는 전 세계 진단 능력의 확대에 따라 원료 사용량을 확대하고 있습니다.

IVD 원료 시장의 성장 원동력은?

IVD 원료 시장의 성장은 진단 검사에 대한 세계 수요 증가, 분석 포맷의 복잡성 증가, 원료 품질에 대한 규제 당국의 모니터링 강화 등 여러 요인에 의해 주도되고 있습니다. 재조합 생산, 합성 화학, 발현 시스템의 발전으로 고성능 부품의 안정적이고 확장 가능한 공급이 가능해졌습니다.

분자진단, 감염병 검사, 맞춤의료 등 최종 용도의 확대로 고도로 특이적이고 안정적인 원료에 대한 수요가 지속적으로 발생하고 있습니다. 새로운 병원균의 출현, 분산형 검사에 대한 관심, 실험실 인프라에 대한 투자 증가는 사용량을 더욱 증가시키고 있습니다. 진단학이 예방의료와 정밀의료의 중심이 되면서 기존 헬스케어 시장과 신흥 헬스케어 시장에서 고품질 IVD 원료에 대한 수요는 계속 증가하고 있습니다.

부문

제품(체외진단용 의약품 항체·항원, 체외진단용 의약품 효소, 체외진단용 의약품 단백질, 체외진단용 의약품 생물학적 완충액, 기타 제품), 기술(임상화학 기술, 면역화학 기술, 분자진단 기술, 기타 기술), 최종사용자(제약·바이오테크놀러지 기업 최종사용자, 진단 실험실 최종사용자, 기타 최종사용자)

조사 대상 기업 사례

  • Aalto Bio Reagents Ltd.
  • AMSBIO(AMS Biotechnology)
  • BBI Solutions
  • Bio-Rad Laboratories, Inc.
  • Bio-Check(UK) Ltd
  • Bioporto Diagnostics
  • Diarect AG
  • EastCoast Bio
  • Fitzgerald Industries Intl.
  • Fujirebio
  • HyTest Ltd
  • Jena Bioscience GmbH
  • Medix Biochemica
  • Meridian Bioscience, Inc.
  • MyBiosource, Inc.
  • QuidelOrtho Corporation
  • RayBiotech, Inc.
  • Rockland Immunochemicals, Inc.
  • Scripps Laboratories, Inc.
  • Sekisui Diagnostics

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.09.03

Global IVD Raw Materials Market to Reach US$35.8 Billion by 2030

The global market for IVD Raw Materials estimated at US$27.7 Billion in the year 2024, is expected to reach US$35.8 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. IVD Antibody & Antigens, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$13.0 Billion by the end of the analysis period. Growth in the IVD Enzymes segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.6 Billion While China is Forecast to Grow at 7.8% CAGR

The IVD Raw Materials market in the U.S. is estimated at US$7.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.3 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global IVD Raw Materials Market - Key Trends & Drivers Summarized

What Role Do Raw Materials Play in the Reliability of In Vitro Diagnostics?

IVD raw materials refer to the essential biological, chemical, and synthetic components used in the manufacture of in vitro diagnostic tests and kits. These include antibodies, antigens, enzymes, nucleotides, reagents, buffers, stabilizers, and control materials. The quality, consistency, and performance of these raw inputs directly impact the sensitivity, specificity, and reproducibility of diagnostic assays used for disease detection, monitoring, and screening.

Demand for reliable IVD raw materials has surged with the rise in molecular diagnostics, point-of-care testing, and infectious disease surveillance. Manufacturers are under pressure to source high-purity, lot-consistent raw materials to ensure regulatory compliance and assay reliability. Biotech firms and research labs also depend on IVD-grade materials for developing new test formats in oncology, cardiology, and infectious diseases.

What Innovations Are Transforming Material Sourcing and Quality Assurance?

Suppliers of IVD raw materials are investing in advanced purification processes, expression systems, and recombinant production technologies to meet stringent quality standards. Monoclonal antibody production, synthetic peptide synthesis, and enzyme engineering are being refined to deliver high-yield, reproducible batches. Recombinant antigens and nucleic acid probes are being used to replace variable biological materials in high-precision test kits.

Material suppliers are also offering pre-validated raw inputs with stability testing, performance documentation, and traceable lot records to streamline regulatory filings by IVD manufacturers. GMP-compliant manufacturing, ISO certifications, and global distribution capabilities are becoming prerequisites as test developers seek reliable, scalable, and audit-ready suppliers. Some companies are developing vertically integrated production lines to ensure uninterrupted supply during public health crises or demand surges.

Where Is Demand Concentrated, and Who Are the Leading Buyers?

Demand is strongest among diagnostic kit manufacturers, molecular test developers, and reference laboratories. Companies developing PCR-based diagnostics, ELISA kits, lateral flow assays, and sequencing platforms rely on a wide range of raw materials tailored to specific detection targets. Research organizations and biotech firms also purchase IVD-grade materials for assay development and clinical validation.

North America and Europe remain key markets due to the concentration of diagnostics firms and regulatory stringency. Asia Pacific is growing rapidly, driven by local manufacturing initiatives, expanding disease surveillance, and increasing export capacity. Public health laboratories, academic institutions, and contract diagnostic manufacturers are expanding their raw material usage as global diagnostic capacity grows.

What Is Driving Growth in the IVD Raw Materials Market?

Growth in the IVD raw materials market is driven by several factors including rising global demand for diagnostic testing, increasing complexity of assay formats, and heightened regulatory scrutiny of material quality. Advances in recombinant production, synthetic chemistry, and expression systems are enabling reliable, scalable supply of high-performance components.

End-use expansion in molecular diagnostics, infectious disease testing, and personalized medicine is creating recurring demand for highly specific and stable raw materials. Emergence of new pathogens, focus on decentralized testing, and growing investment in lab infrastructure are further boosting usage. As diagnostics become central to preventive and precision medicine, the need for high-quality IVD raw materials continues to grow in both established and emerging healthcare markets.

SCOPE OF STUDY:

The report analyzes the IVD Raw Materials market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers, Other Products); Technology (Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology, Other Technologies); End-Use (Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

  • Aalto Bio Reagents Ltd.
  • AMSBIO (AMS Biotechnology)
  • BBI Solutions
  • Bio-Rad Laboratories, Inc.
  • Bio-Check (UK) Ltd
  • Bioporto Diagnostics
  • Diarect AG
  • EastCoast Bio
  • Fitzgerald Industries Intl.
  • Fujirebio
  • HyTest Ltd
  • Jena Bioscience GmbH
  • Medix Biochemica
  • Meridian Bioscience, Inc.
  • MyBiosource, Inc.
  • QuidelOrtho Corporation
  • RayBiotech, Inc.
  • Rockland Immunochemicals, Inc.
  • Scripps Laboratories, Inc.
  • Sekisui Diagnostics

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • IVD Raw Materials - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for In Vitro Diagnostics Across Infectious Disease, Cancer, and Genetic Testing Drives Consumption of Raw Materials
    • Expansion of Point-of-Care and Home Diagnostics Strengthens Need for High-Quality Antibodies, Antigens, and Buffers
    • OEM Focus on Recombinant Protein Engineering and Monoclonal Antibody Production Enhances Specificity and Stability
    • Growth in Molecular Diagnostics and PCR-Based Assays Throws Spotlight on High-Fidelity Enzymes and Primers
    • Increasing Emphasis on Supply Chain Resilience and Material Traceability Supports Strategic Sourcing of IVD Inputs
    • OEM Investment in GMP-Compliant Raw Material Manufacturing Improves Quality Assurance for Diagnostic Kit Producers
    • Rising Adoption of Multiplex Assays and Rapid Diagnostic Tests Fuels Need for Custom Coating and Blocking Reagents
    • OEM Development of Bulk Supply Agreements With Test Kit Manufacturers Enhances Scalability and Delivery Reliability
    • Growth in Companion Diagnostics and Personalized Medicine Expands Use of Specialized Biomarker Reagents
    • OEM Innovation in Lyophilized and Room-Temperature Stable Raw Materials Supports Distribution in Low-Resource Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World IVD Raw Materials Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for IVD Raw Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for IVD Antibody & Antigens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for IVD Antibody & Antigens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for IVD Antibody & Antigens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for IVD Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for IVD Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for IVD Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for IVD Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for IVD Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for IVD Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for IVD Biological Buffers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for IVD Biological Buffers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for IVD Biological Buffers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Clinical Chemistry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Immunochemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Immunochemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Immunochemistry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Molecular Diagnostics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: USA 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • JAPAN
    • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • CHINA
    • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: China 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: China 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: China 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • EUROPE
    • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for IVD Raw Materials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • FRANCE
    • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: France 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: France 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: France 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • GERMANY
    • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: UK 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: UK 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: UK 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for IVD Raw Materials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Australia 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • INDIA
    • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: India 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: India 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: India 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: South Korea 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for IVD Raw Materials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Latin America 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Argentina 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Brazil 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: Mexico 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for IVD Raw Materials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Middle East 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Iran 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Israel 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: UAE 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • AFRICA
    • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 313: Africa 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제